- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05171738
Distalization Via Skeletally-anchored Distaljet Appliance With Two Approaches of Micro-osteoperforations
April 18, 2022 updated by: khaled abd el khaliq hendy, Al-Azhar University
Appraisal of Two Different Approaches of Micro-osteoperforations During Maxillary Molar Distalization Via Skeletally-anchored Distaljet Appliance
study will be directed to evaluate two approaches of micro-osteoperforations during maxillary molar distalization.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Maxillary molar distalization via skeletally anchored distal jet appliance randomly divided into two equal groups
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt
- Al Azhar University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 17 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Inclusion criteria:
All patients should satisfy the following criteria:-
- Age range from 13-17 years.
- Bilateral Class II molar relationship.
- Skeletal Class I or mild Class II relationship.
- Normodivergent skeletal pattern
- No posterior crowding or diastemas.
- Fully erupted maxillary first and second molars.
- Congenitally missing or extracted third molars.
- Good oral and general health.
- No systemic disease/medication that could interfere with OTM.
- No previous orthodontic treatment.
Exclusion Criteria:
Exclusion criteria:
- Patient diagnosed to have an indication for non-extraction approach.
- Poor oral hygiene or periodontally compromised patient.
- Patient with craniofacial anomalies or previous history of trauma, bruxism or parafunctions.
- Previous orthodontic treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: group(1)
Group I: will include ten patients undergo maxillary molar distalization using skeletally anchored distal jet appliance with MOPs that will be performed buccally on repeated basis on two sides before and during maxillary molar distalization
|
used from day one and activated every month
|
|
ACTIVE_COMPARATOR: group(2)
Group II:will include ten patients undergo maxillary molar distalization using skeletally anchored distal jet appliance with MOPs that will be performed both buccally and palatally on repeated basis on two sides before and during maxillary molar distalization.
|
used from day one and activated every month
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in molar postion
Time Frame: from start of treatment until study completion, an average of 1 year
|
using cephalometric x_ray for measurment
|
from start of treatment until study completion, an average of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 1, 2021
Primary Completion (ANTICIPATED)
October 1, 2023
Study Completion (ANTICIPATED)
November 1, 2023
Study Registration Dates
First Submitted
November 29, 2021
First Submitted That Met QC Criteria
December 19, 2021
First Posted (ACTUAL)
December 29, 2021
Study Record Updates
Last Update Posted (ACTUAL)
April 25, 2022
Last Update Submitted That Met QC Criteria
April 18, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 788/309
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.